what are the potential side effects of glp-1 drugs Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity Weight-Loss Medication Side Effects and

The glucagon receptor is involved in mediating the body weight-lowering effects of oxyntomodulin

Short-acting GLP-1 RAs are resistant to DPP4 owing to their structural modifications, and longer-acting molecules have undergone some structural modifications to enhance their duration of action, e.g

Dawkins says, Since the GIP [glucose-dependent insulinotropic polypeptide] hormone acts as an antiemetic, the dual agonist tirzepitide is associated with fewer adverse side effects and better tolerance. References 1

Medicare and Medicaid Medicaid coverage varies by state

But in most cases, weve seen that patients exclusively seeking weight loss usually need higher doses of the same drug

doi: 10.1038/s41591-024-03015-5